This suggests that apart from genetic mutations, alternative mechanisms should exist to promote the persistent activation of the JAK/STAT signaling pathway in HCC, such as overproduction of upstream ligands (e.g., cytokines and growth factors) or downregulation of negative regulators of the pathway. The gene discussed is SOAT1; the disease is hepatocellular carcinoma.